Understanding factors affecting Chinese medical staff’s fear of receiving the fourth dose of COVID-19 vaccine: A cross-sectional study in Taizhou-Reference-Cited by-同舟云学术

Understanding factors affecting Chinese medical staff’s fear of receiving the fourth dose of COVID-19 vaccine: A cross-sectional study in Taizhou

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Huang Li-Li¹,Hong Wei-Wen²,Hu Wei-Wei³,Guan Xian-Hua⁴,Jiang Yan-Hong⁵

Affiliation:

1. Department of Emergency, Taizhou First People’s Hospital, Taizhou, Zhejiang, China

2. Department of Anus & Intestine Surgery, Taizhou First People’s Hospital, Taizhou, Zhejiang, China

3. Department of General Surgery, Taizhou First People’s Hospital, Taizhou, Zhejiang, China

4. Intensive Care Unit, Taizhou First People’s Hospital, Huangyan, Zhejiang, China

5. Department of Outpatient, Taizhou First People’s Hospital, Taizhou, Zhejiang, China

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2261201

Reference31 articles.

1. World health organization: coronavirus disease (COVID-19) pandemic. [accessed 2022 Sept 12]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

2. Comprehensive group of joint prevention and control mechanism of the health commission of the People’s Republic of China. Notice on further optimizing the implementation of new crown Pneumonia Epidemic prevention and control measures[eb/OL]. 2022 Dec 7. http://www.nhc.gov.cn/xcs/gzzcwj/202212/8278e7aa7aee34e5bb378f0e0fc94e0f0.shtml.

3. Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety

4. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

5. Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel